Product Details
Acriptega Tablets
Dolutegravir (Dolutegravir Sodium); Lamivudine; Tenofovir Disoproxil Fumarate50 mg; 300 mg; 300 mg
Tablet
ROA
Oral
Applicant Name
Healthline Limited
NRN
B4-9927
Status
Active
Composition
Each film coated tablet contains: Dolutegravir (as Dolutegravir Sodium Base) 50 mg, Lamivudine USP 300 mg, Tenofovir Disoproxil Fumarate ( equivalent to Tenofovir Disoproxil Base 245 mg) 300 mg Excipients with known effect: Lactose Monohydrate, Mannitol
ATC Code/ATCvet Code
J05AR27
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 x 30's,1 x 90's,1 x 180's (in HDPE bottle)
Product Description
Film coated tablet A white to off-white, film coated, capsule shaped, biconvex, beveled edge tablet debossed with M on one side and LTD on the other side of the tablet ACRIPTEGA TABLETS DOLUTEGRAVIR/LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE TABLETS 50MG/300MG/300MG ACTIVE INGREDIENTS: DOLUTEGRAVIR 50MG, TENOFOVIR DISPROXIL FUMARATE 300MG,LAMIVUDINE 300MG. INACTIVE INGREDIENTS:MANNITOL,MICROCRYSTALLINE CELLULOSE,PROVIDONE, MAGNESIUM STEARATE, PURIFIED WATER. B4-9927 Drugs Imported Product 1*30,1*90,1*180 29-04-2024 HEALTHLINE LIMITED, 29,ADENIYI JONES IKEJA LAGOS 07081123545 healthline.ng@gmail.com MYLAN LABORATOREIS LIMITED, PLOT NO. 11, 12 & 13, INDORE SPECIAL ECONOMIC ZONE, PHARMA ZONE, PHASE-II, SECTOR -III, PITHAMPUR 454775, DIST. DHAR, MADHYA PRADESH
Manufacturer Name
Mylan Laboratories Limited
Manufacturer Country
INDIA
Approval Date
2025-04-30
Expiry Date
2030-04-29